BioCardia Inc logo

BCDA - BioCardia Inc News Story

$3.3 -0.1  -2.1%

Last Trade - 12/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £39.4m
Enterprise Value £24.2m
Revenue £103k
Position in Universe 5555th / 6856

BRIEF-Biocardia Announces Positive Preclinical Results Supporting Investigational New Drug Application For Anti-Inflammatory Cell Therapy In Heart Failure

Tue 5th May, 2020 12:17pm
BioCardia Inc  BCDA.O :
    * BIOCARDIA ANNOUNCES POSITIVE PRECLINICAL RESULTS
SUPPORTING
INVESTIGATIONAL NEW DRUG APPLICATION FOR ANTI-INFLAMMATORY CELL
THERAPY IN HEART FAILURE
    * BIOCARDIA - PLANNING FURTHER EXPLORATION & DISCUSSION WITH
FDA
ON USE OF ITS ALLOGENIC CELLS FOR COVID-19 RELATED ACUTE
RESPIRATORY DISTRESS SYNDROME
    * BIOCARDIA - INTENDS TO SUBMIT AN IND FOR USE OF ITS NK1R+
MSC
DELIVERED VIA IV INFUSION FOR ARDS CAUSED BY COVID-19

Source text for Eikon:  ID:nGNXZ5FZN 
Further company coverage:  BCDA.O
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.